It’s all in the details

Dr. Sarkar and his nanotechnology laboratory team are primarily dedicated to the study of neuroscience as it relates to cancer and Parkinson’s disease.  Using the latest technology available, they hope to directly improve clinical treatment options by furthering the understanding of biology and disease progression.  It is at the most elemental level of biology that they will find the root causes of illness and disease. 

More About Our Research More about Our Patients

 

What's New?


A New Home

September 14, 2010

Sarkar Lab Moves to University of Arkansas for Medical Sciences (UAMS)

Read More

Operative Education


Pamphlets:

Brain Surgery Guide

(View All)

Clinical Trial Information


Parkinson’s Clinical Trial

July 21, 2009

Glutamic Acid Decarboxylase (GAD) genes are transfered to the subthalamic nuclei of the brain for anticipated relief of symptoms associated with Parkinson’s Disease.

Continue Reading